BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18312300)

  • 1. Mood and malignancy: head and neck cancer and depression.
    Archer J; Hutchison I; Korszun A
    J Oral Pathol Med; 2008 May; 37(5):255-70. PubMed ID: 18312300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer and depression.
    Somerset W; Stout SC; Miller AH; Musselman D
    Oncology (Williston Park); 2004 Jul; 18(8):1021-34; discussion 1035-6, 1047-8. PubMed ID: 15328896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome, activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in depressive disorder.
    Martinac M; Pehar D; Karlović D; Babić D; Marcinko D; Jakovljević M
    Acta Clin Croat; 2014 Mar; 53(1):55-71. PubMed ID: 24974667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of prevalence and associated factors of depressive disorder between patients with head and neck cancer and those with lung cancer at a tertiary hospital in Taiwan: a cross-sectional study.
    Lee Y; Hung CF; Chien CY; Lin PY; Lin MC; Wang CC; Lu HI; Chen YC; Chong MY; Wang LJ
    BMJ Open; 2020 Jun; 10(6):e037918. PubMed ID: 32601116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of anxiety and mood disorders on physical disease: the worried not-so-well.
    Sobel RM; Markov D
    Curr Psychiatry Rep; 2005 Jun; 7(3):206-12. PubMed ID: 15935135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression among long-term survivors of head and neck cancer treated with radiation therapy.
    Chen AM; Daly ME; Vazquez E; Courquin J; Luu Q; Donald PJ; Farwell DG
    JAMA Otolaryngol Head Neck Surg; 2013 Sep; 139(9):885-9. PubMed ID: 23949013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive symptoms and actigraphy-measured circadian disruption predict head and neck cancer survival.
    Cash E; Duck CR; Brinkman C; Rebholz W; Albert C; Worthen M; Jusufbegovic M; Wilson L; Bumpous JM
    Psychooncology; 2018 Oct; 27(10):2500-2507. PubMed ID: 30117225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions.
    Cameron OG
    Essent Psychopharmacol; 2006; 7(1):24-34. PubMed ID: 16989290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercortisolemia and depression.
    Gillespie CF; Nemeroff CB
    Psychosom Med; 2005; 67 Suppl 1():S26-8. PubMed ID: 15953796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression and cancer: mechanisms and disease progression.
    Spiegel D; Giese-Davis J
    Biol Psychiatry; 2003 Aug; 54(3):269-82. PubMed ID: 12893103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways.
    Zimmaro LA; Sephton SE; Siwik CJ; Phillips KM; Rebholz WN; Kraemer HC; Giese-Davis J; Wilson L; Bumpous JM; Cash ED
    Cancer; 2018 Mar; 124(5):1053-1060. PubMed ID: 29355901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do anxiety and depression have a common pathophysiological mechanism?
    Boyer P
    Acta Psychiatr Scand Suppl; 2000; (406):24-9. PubMed ID: 11131467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune activation and depression in the elderly].
    Maas DW; Westendorp RG; van der Mast RC
    Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1413-7. PubMed ID: 18624003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological distress in patients with head and neck cancer: review.
    Frampton M
    Br J Oral Maxillofac Surg; 2001 Feb; 39(1):67-70. PubMed ID: 11178847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between depressive symptoms and initial quality of life and function in head and neck cancer.
    Chan JY; Lua LL; Starmer HH; Sun DQ; Rosenblatt ES; Gourin CG
    Laryngoscope; 2011 Jun; 121(6):1212-8. PubMed ID: 21541945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot randomized controlled trial of a brief early intervention for reducing posttraumatic stress disorder, anxiety and depressive symptoms in newly diagnosed head and neck cancer patients.
    Kangas M; Milross C; Taylor A; Bryant RA
    Psychooncology; 2013 Jul; 22(7):1665-73. PubMed ID: 23042612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss after head and neck cancer: A dynamic relationship with depressive symptoms.
    Van Liew JR; Brock RL; Christensen AJ; Karnell LH; Pagedar NA; Funk GF
    Head Neck; 2017 Feb; 39(2):370-379. PubMed ID: 27704695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and environmental factors influence the hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone infusion in offspring of mothers with or without mood disorders.
    Ronsaville DS; Municchi G; Laney C; Cizza G; Meyer SE; Haim A; Radke-Yarrow M; Chrousos G; Gold PW; Martinez PE
    Dev Psychopathol; 2006; 18(1):173-94. PubMed ID: 16478558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of some new factors in the pathophysiology of depression and cardiovascular disease: overview of recent research.
    Kitzlerová E; Anders M
    Neuro Endocrinol Lett; 2007 Dec; 28(6):832-40. PubMed ID: 18063922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.